Prof. Om Kurmi who leads the Nepal Family Cohort Study (NeFCoS) joined the Bournemouth University (BU) team today for a research planning meeting in Bournemouth today. Dr. Om Kurmi, Associate Professor Research in the Centre for Healthcare and Communities at Coventry University. The BU team comprises Dr. Pramod Regmi (Principal Academic-International Health), Prof. Carol Clark (Professor in Physiotherapy), Prof. Edwin van Teijlingen (Professor of Reproductive Health), Dr. Rebecca Neal (Principal Lecturer in Exercise Physiology) and Dr. Vanora Hundley (Professor of Midwifery).
The Nepal Family Cohort Study (NeFCoS) is a multidisciplinary cohort study into the prevalence, incidence, and determinants of various diseases from childhood to adulthood in children and their parents [1]. NeFCoS has just started to collect date for the first round of follow-up.
Today’s meeting was organised by Dr. Neal and supported by BU’s QR funds.
- Kurmi, O.P., Chaudhary, N., Delanerolle, G., Bolton, C.E., Pant, P.R., Regmi, P., Gautam, S., Satia, I., Simkhada, P., Kyrou, I., Sigdel, T.K., Hundley, V., Dali, P.R., Lokke, A., Hubert Lam, K.B., Bennett, D., Custovic, A., van Teijlingen, E., Gill, P. Randeva, H., O’Byrne, P.M., and Nepal Family Cohort Collaborators Group, Nepal Family Cohort Study: A Study Protocol, BMJ Open 14:e088896. doi:10.1136/ bmjopen-2024-088896



















Final day of the ESRC Festival of Social Science
Using Art to enhance Research
Register now to attend the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
Portrait Concert featuring BU academic at L’Espace du Son Festival 2025, Brussels
From Clinical Applications to Neuro-Inspired Computation
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease